Combination of pembrolizumab and 125I attenuates the aggressiveness of non‑small cell lung cancer
Shuo Wang(Tianjin Medical University Cancer Institute and Hospital)
Cited by 6
Related Papers
Fn-OMV potentiates ZBP1-mediated PANoptosis triggered by oncolytic HSV-1 to fuel antitumor immunity
|Nature Communications|2024|72
E3 ubiquitin ligases Cbl‐b and c‐Cbl downregulate <scp>PD</scp>‐L1 in <i><scp>EGFR</scp></i> wild‐type non‐small cell lung cancer
|FEBS Letters|2018|71
FOXF2 reprograms breast cancer cells into bone metastasis seeds
|Nature Communications|2019|68